Edesa Biotech (EDSA) Exchange Rate Effect (2013 - 2025)
Edesa Biotech (EDSA) posted Exchange Rate Effect of -$8509.0 for Q4 2025, up 75.69% sequentially from -$35007.0 in Q3 2025, and up 69.78% YoY from -$5011.7 in Q4 2024.
Edesa Biotech (EDSA) Exchange Rate Effect (2013 - 2025) Analysis & Trends
Edesa Biotech has reported Exchange Rate Effect for 13 years, with the latest figure at -$8509.0 in Q4 2025.
- Quarterly Exchange Rate Effect rose 69.78% year-over-year to -$8509.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $65867.0 (up 207.56% YoY) and the FY2025 annual result came in at $46216.0, up 278.42% from the prior year.
- Exchange Rate Effect improved to -$8509.0 in Q4 2025 per EDSA's latest filing, from -$35007.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $193540.0 in Q2 2021 and troughed at -$99434.0 in Q1 2021.
- A 5-year average of $462.75 and a median of -$8401.0 in 2024 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2021 and 2025: Exchange Rate Effect sank 676.86% in 2021, then jumped 2099.36% in 2025.
- Over 5 years, Exchange Rate Effect stood at $23740.0 in 2021, then jumped by 146.87% to $58608.0 in 2022, then sank by 87.76% to $7176.0 in 2023, then tumbled by 492.42% to -$28160.0 in 2024, then surged by 69.78% to -$8509.0 in 2025.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$8509.0, -$35007.0, and $165807.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.55 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.20 Bn | 60.02 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.40 Bn | 55.26 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.36 Bn | 28.05 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.74 Bn | 10.34 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.17 Bn | 26.33 Bn | - | - |
| 10 | Edesa Biotech | 42.43 Mn | 42.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8,509.00 |
| Dec 31, 2025 | -8,509.00 |
| Sep 30, 2025 | -35,007.00 |
| Sep 30, 2025 | -35,007.00 |
| Jun 30, 2025 | 165,807.00 |
| Jun 30, 2025 | 165,807.00 |
| Mar 31, 2025 | -56,424.00 |
| Mar 31, 2025 | -56,424.00 |
| Dec 31, 2024 | -28,160.00 |
| Dec 31, 2024 | -28,160.00 |
| Sep 30, 2024 | -5,090.00 |
| Sep 30, 2024 | -5,090.00 |
| Jun 30, 2024 | -8,293.00 |
| Jun 30, 2024 | -8,293.00 |
| Mar 31, 2024 | -19,696.00 |
| Mar 31, 2024 | -19,696.00 |
| Dec 31, 2023 | 7,176.00 |
| Dec 31, 2023 | 7,176.00 |
| Sep 30, 2023 | -40,216.00 |
| Sep 30, 2023 | -40,216.00 |